| Non-symmetrical furan-amidines as novel leads for the treatment of cancer and malaria S Alnabulsi, E Santina, I Russo, B Hussein, M Kadirvel, A Chadwick, ... European Journal of Medicinal Chemistry 111, 33-45, 2016 | 32 | 2016 |
| Synthesis of piperazinylalkyl ester prodrugs of ketorolac and their in vitro evaluation for transdermal delivery A Qandil, S Al-Nabulsi, B Al-Taani, B Tashtoush Drug development and industrial pharmacy 34 (10), 1054-1063, 2008 | 27 | 2008 |
| High performance liquid chromatography (HPLC) with fluorescence detection for quantification of steroids in clinical, pharmaceutical, and environmental samples: a review F Hameedat, S Hawamdeh, S Alnabulsi, A Zayed Molecules 27 (6), 1807, 2022 | 26 | 2022 |
| Explaining the autoinhibition of the SMYD enzyme family: A theoretical study NA Al-Shar’i, SM Alnabulsi Journal of Molecular Graphics and Modelling 68, 147-157, 2016 | 20 | 2016 |
| Evaluation of analogues of furan-amidines as inhibitors of NQO2 S Alnabulsi, B Hussein, E Santina, I Alsalahat, M Kadirvel, RN Magwaza, ... Bioorganic & medicinal chemistry letters 28 (8), 1292-1297, 2018 | 16 | 2018 |
| Pim kinase inhibitors in cancer: Medicinal chemistry insights into their activity and selectivity S Alnabulsi, EA Al-Hurani Drug discovery today 25 (11), 2062-2069, 2020 | 15 | 2020 |
| Amino-carboxamide benzothiazoles as potential LSD1 hit inhibitors. Part I: Computational fragment-based drug design S Alnabulsi, EA Al-Hurani, T El-Elimat Journal of Molecular Graphics and Modelling 93, 107440, 2019 | 12 | 2019 |
| New Efficient Synthesis of 1, 2, 4-Trisubstituted Furans by a Sequential Passerini/Wittig/Isomerization Reaction Starting from Baylis–Hillman β-Bromo Aldehydes ZL Ren, M Sun, ZR Guan, MW Ding Synlett 29 (01), 106-110, 2018 | 12 | 2018 |
| Simultaneous RP-LC determination of ketorolac and its piperazinylalkyl ester prodrugs AM Qandil, BM Tashtoush, BM Al-Taani, SM Al-Nabulsi, F Al-Zogoul Chromatographia 67, 287-291, 2008 | 12 | 2008 |
| Coumarins, dihydroisocoumarins, a dibenzo-α-pyrone, a meroterpenoid, and a merodrimane from Talaromyces amestolkiae T El-Elimat, M Figueroa, HA Raja, S Alnabulsi, NH Oberlies Tetrahedron letters 72, 153067, 2021 | 8 | 2021 |
| Hit identification of SMYD3 enzyme inhibitors using structure-based pharmacophore modeling SM Alnabulsi, NA Al-shar’i Future Medicinal Chemistry 11 (10), 1107-1117, 2019 | 7 | 2019 |
| Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin: in vitro: and: in silico: studies H Mashaqbeh, R Obaidat, NA Al-Shar’i, T El-Elimat, S Alnabulsi Research in Pharmaceutical Sciences 17 (4), 334-349, 2022 | 4 | 2022 |
| Design, synthesis, and biological evaluation of SMYD3 inhibitors possessing N-thiazole benzenesulfonamide moiety as potential anti-cancer agents SA Audat, NA Al-Shar'i, BA Al-Oudat, S Alnabulsi Journal of Saudi Chemical Society 26 (3), 101482, 2022 | 4 | 2022 |
| Synthesis and Biological Evaluation of Carbonic Anhydrase III and IX Inhibitors using Gas Chromatography with Modified pH Sensitive Pellets B Hussein, LMS Bourghli, M Alzweiri, Y Al-Hiari, MA Sini, S Alnabulsi, ... Jordan Journal of Pharmaceutical Sciences 16 (2), 426-439, 2023 | | 2023 |
| Hit-to-lead optimization of amino-carboxamide benzothiazoles as LSD1 inhibitors D Al bustanji, S Alnabulsi, EA Al-Hurani Medicinal Chemistry Research 32 (5), 910-929, 2023 | | 2023 |
| DESIGN, SYNTHESIS & EVALUATION OF NOVEL NQO2 INHIBITORS S Freeman, S Alnabulsi, E Santina, A Chadwick, R Bryce, E Bichenkova, ... 5th International Conference on Drug Discovery and Therapy, 2013 | | 2013 |
| Synthesis and evaluation of novel NQO2 inhibitors SMO Alnabulsi PQDT-Global, 2013 | | 2013 |
